Academic journals

Herbalife Nutrition Education Scholarships Awarded by The American Society for Nutrition and The Academy of Nutrition and Dietetics

Retrieved on: 
Friday, June 11, 2021
Retail, Specialty, Fitness & Nutrition, Health, American Society for Nutrition, Nutrition, Herbalife Nutrition, ASN, Academic journals, Organizations, American Society of Nephrology, the American Society for Nutrition, NEP, Herbalife Nutrition Ltd., THE AMERICAN SOCIETY FOR NUTRITION, NEP, HERBALIFE NUTRITION LTD.

ASN is the nations leading scientific society devoted to advancing nutrition research and its clinical applications.

Key Points: 
  • ASN is the nations leading scientific society devoted to advancing nutrition research and its clinical applications.
  • The American Society for Nutrition (ASN) is the preeminent professional organization for nutrition research scientists and clinicians around the world.
  • ASN publishes four peer-reviewed journals and provides education and professional development opportunities to advance nutrition research, practice and education.
  • Through the Companys global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.

Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021

Retrieved on: 
Thursday, June 10, 2021
Medical Supplies, Medical devices, Health, Manufacturing, General Health, Other Manufacturing, Academic journals, Quidel Corporation, Natural sciences, Branches of biology, NASDAQ, Assay, Molecular diagnostics, Virology

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Raymond James Human Health Innovation Conference 2021 to be held virtually on Monday, June 21, 2021.

Key Points: 
  • Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Raymond James Human Health Innovation Conference 2021 to be held virtually on Monday, June 21, 2021.
  • Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on that day at 1:20 p.m. Eastern time (10:20 a.m. Pacific time) in a question-and-answer teleconference format.
  • During the presentation, the company will discuss business and financial developments and trends.
  • The company's statements may contain or constitute material information that has not been previously disclosed.

Color Detection Sensor Market to see $ 812.04 Mn growth during 2021-2025 | Key Vendor Insights, Major Drivers, and Forecast Through 2025 | Technavio

Retrieved on: 
Friday, June 4, 2021
Sensors, Photonic Sensors, Academic journals, Fiber-optic sensor, Photonics, Technology, Electromagnetism

NEW YORK, June 3, 2021 /PRNewswire/ --The color detection sensor market is expected to grow by USD 812.04 million during 2021-2025, according to Technavio.

Key Points: 
  • NEW YORK, June 3, 2021 /PRNewswire/ --The color detection sensor market is expected to grow by USD 812.04 million during 2021-2025, according to Technavio.
  • The report offers a detailed analysis of the impact of the COVID-19 pandemic on the color detection sensor market in optimistic, probable, and pessimistic forecast scenarios.
  • Discover information technology industry potential and make informed business decisions based on qualitative and quantitative evidence highlighted exclusively for you in Technavio reports.
  • Key Considerations for Market Forecast:
    Related Reports on Information Technology:
    GlobalPhotonic Sensor Market- Global photonic sensor market is segmented bytype (fiber optic sensors, bio-photonic sensors, image sensors, and others), application (defense and security, industrial infrastructure, public infrastructure, medical, and others), and geography (North America, Europe, APAC, South America, and MEA).

Imago BioSciences Appoints Wan-Jen Hong, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, June 3, 2021
Research, Genetics, Clinical trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Oncology, Myeloproliferative neoplasm, Imago, Academic journals

Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the appointment of Wan-Jen Hong, M.D., as chief medical officer.

Key Points: 
  • Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the appointment of Wan-Jen Hong, M.D., as chief medical officer.
  • Dr. Hong joins Imago from Genentech, where she served as Group Medical Director in their late-stage clinical development group.
  • Imago has generated significant data on its lead asset bomedemstat in several indications, said Dr. Wan-Jen Hong, chief medical officer, Imago BioSciences.
  • I am excited to work with the Imago team to develop bomedemstat as a new treatment option for patients with unmet medical needs.

Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil

Retrieved on: 
Thursday, June 3, 2021
Life sciences, Academic journals, Ifenprodil, Phenols, Piperidines, Pharmacology, Clinical Pharmacology: Advances and Applications, Pharmaceutical industry, Pancreatic cancer, Pharmaceutical sciences

VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc.(CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the Company or Algernon) announces it has initiated a new clinical research program for pancreatic cancer (PC) and NP-120 (Ifenprodil).

Key Points: 
  • VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc.(CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the Company or Algernon) announces it has initiated a new clinical research program for pancreatic cancer (PC) and NP-120 (Ifenprodil).
  • Ifenprodil demonstrated a significant anti-tumour effect in a PC animal model which was reported in a paper published in the Dove Press Journal, Clinical Pharmacology: Advances and Applications.
  • The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years.
  • Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

Celebrating 20 Years of Certis; Company Rebrand Cements Legacy Leadership in Biologicals

Retrieved on: 
Wednesday, June 2, 2021
Agriculture, Natural Resources, Other Manufacturing, Manufacturing, Food industry, Academic journals, Biologicals, Intensive farming, Agriculture, Publications, Periodicals

Against the backdrop of 20 successful years as Certis USA, the company today announced a brand change to Certis Biologicals .

Key Points: 
  • Against the backdrop of 20 successful years as Certis USA, the company today announced a brand change to Certis Biologicals .
  • The new brand acknowledges the importance of biological-based crop inputs to farmers around the globe and cements the companys legacy of leadership as manufacturer, supplier and innovator of biological crop protection solutions.
  • Certis is the name that is synonymous with biologicals in agriculture, OShea said of the new brand.
  • Certis Biologicals supplies the most comprehensive portfolio of biologicals for crop protection in commercial agriculture, garden and greenhouse markets.

Kansas State University Educator, Researcher Kevin L. Sauer Becomes 2021-2022 President of Academy of Nutrition and Dietetics

Retrieved on: 
Tuesday, June 1, 2021
Nutrition, Dietitian, Health, Academic journals, Academy of Nutrition and Dietetics

Kevin L. Sauer began his one-year term as 2021-2022 President of the Academy of Nutrition and Dietetics on June 1.

Key Points: 
  • Kevin L. Sauer began his one-year term as 2021-2022 President of the Academy of Nutrition and Dietetics on June 1.
  • Sauer specializes in administrative dietetics and has previous experience in health care and food and nutrition services, school nutrition, and university dining.
  • He is an accomplished educator and researcher who has been honored locally and nationally for his work.
  • Representing more than 112,000 credentialed nutrition and dietetics practitioners, the Academy of Nutrition and Dietetics is the world's largest organization of food and nutrition professionals.

Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis

Retrieved on: 
Monday, May 31, 2021
Analytical chemistry, Bioanalysis, Pharmacokinetics, Toxicology, Natural sciences, Academic journals, Physical sciences

ADELAIDE, AUS, May 31, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Gyros Protein Technologies and BioAnalysis Zone to share the latest on singlicate analysis on the Gyrolab platform.

Key Points: 
  • ADELAIDE, AUS, May 31, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Gyros Protein Technologies and BioAnalysis Zone to share the latest on singlicate analysis on the Gyrolab platform.
  • Agilex Biolabs' Principal Method Development Scientist, Morgan Evans will present with Gyros Protein Technologies' Application & Service Director EMEA and Asia Pacific, John Chappell for a comprehensive webinar titled Singlicate analysis on the Gyrolab platform.
  • Over the last several years singlet analysis has become a hot topic within the world of LBA non-regulated and regulated bioanalysis.
  • This webinar will look at the overall landscape of singlet analysis and through Agilex Biolabs case studies discuss the use of the Gyrolab technology.

Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference

Retrieved on: 
Monday, May 24, 2021
Technology, Health, Data management, Academic journals, Quidel Corporation, Natural sciences, Branches of biology, Laboratory techniques, NASDAQ, Molecular diagnostics, Assay, Virology

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 41st Annual Growth Stock Conference to be held virtually on Thursday, June 3, 2021.

Key Points: 
  • Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 41st Annual Growth Stock Conference to be held virtually on Thursday, June 3, 2021.
  • Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on that day at 10:40 a.m. Central time (8:40 a.m. Pacific time) in a question-and-answer teleconference format.
  • During the presentation, the company will discuss business and financial developments and trends.
  • The company's statements may contain or constitute material information that has not been previously disclosed.

Using Gene-Therapy to Target RAS in Gliomas

Retrieved on: 
Monday, May 24, 2021
Academic journals, Articles, Education, Experimental Biology and Medicine, Interdisciplinarity, Glioma, Medicine, Science

Gliomas are the most common type of central nervous system tumor in humans, with approximately 250,000 cases reported annually worldwide.

Key Points: 
  • Gliomas are the most common type of central nervous system tumor in humans, with approximately 250,000 cases reported annually worldwide.
  • Experimental Biology and Medicine is a global journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences.
  • Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine.
  • If you are interested in publishing in the journal, please visit http://ebm.sagepub.com .